Traynor Capital Management »

Galectin Therapeutics shares owned by Traynor Capital Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Traynor Capital Management from 13F filings

Historical chart of Traynor Capital Management investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Traynor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Traynor Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $83k 35k 2.39
2023-12-31 $58k 35k 1.66
2023-09-30 $67k 35k 1.92